The introduction of Retatrutide in the UK is creating significant excitement within the weight management community. This novel dual medication – targeting both GLP-1 and GIP – offers a potentially new solution to addressing obesity . As of now , options have been restricted for many, and Retatrutide represents a hopeful prospect for people see